Wilhelmus Groenhuysen

2015

In 2015, Wilhelmus Groenhuysen earned a total compensation of $3.3M as Chief Financial Officer at NovoCure, a 172% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$330,330
Option Awards$2,344,448
Salary$600,600
Other$17,544
Total$3,292,922

Groenhuysen received $2.3M in option awards, accounting for 71% of the total pay in 2015.

Groenhuysen also received $330.3K in non-equity incentive plan, $600.6K in salary and $17.5K in other compensation.

Rankings

In 2015, Wilhelmus Groenhuysen's compensation ranked 2,810th out of 13,638 executives tracked by ExecPay. In other words, Groenhuysen earned more than 79.4% of executives.

ClassificationRankingPercentile
All
2,810
out of 13,638
79th
Division
Manufacturing
997
out of 5,190
81st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
118
out of 760
85th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
67
out of 466
86th
Industry
Surgical and Medical Instruments and Apparatus
38
out of 293
87th
Source: SEC filing on March 28, 2017.

Groenhuysen's colleagues

We found two more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2015.

2015

Asaf Danziger

NovoCure

Chief Executive Officer

2015

Michael Ambrogi

NovoCure

Chief Operating Officer

News

In-depth

You may also like